Project Grant K23DA063650
Award Date 9/1/25
Completion Date 8/31/30
Dollars Obligated $195K
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Connecticut, USA
Similar Awards
- This federal Project Grant award in the amount of $688,271, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a research project led by Yale University to examine spatial and temporal variability in a state's illicit drug market. The key products and services to be delivered under this grant include: Expanding existing street-based testing of drug samples from representative samples of people who use drugs (PWUD)...
- This Cooperative Agreement award is funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The $818,486 award will support the development and validation of the Stimulant Use Disorder Severity Scale (STUDSS), a clinical outcome assessment tool, at sites in Connecticut and California. This work aims to create a psychometrically sound measure to support medication development for...
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $306,528 to Addinex Technologies, Inc. to adapt their existing medication management system for use in decentralized clinical trials for substance use disorder (SUD). The primary goal is to develop a system that allows for at-home dispensing of medication, with features such as smartphone app-controlled dispensers using one-time passcodes,...
- This $1,585,991 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a study to evaluate the use of transcranial direct current stimulation (tDCS) combined with cognitive reappraisal training to reduce craving and cue-reactivity in individuals with cocaine use disorder. The study will conduct a double-blind randomized trial with four groups (n=120 total) to assess the synergistic effects of real vs....
- This Project Grant, awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will investigate the role of corticotrophin releasing factor type 1 receptor (CRF1R) and L-type calcium channels (LTCC) in the prelimbic cortex (PRL)-nucleus accumbens core (NAcc) circuit during abstinence, and its impact on stress-induced relapse in cocaine use disorder (CUD). The $111,438 award to Yale University will seek to determine the regulation of...
- This federal Project Grant award for $896,804, provided by the National Institute on Drug Abuse (NIDA) through the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop a cost-based epidemiological planning tool to address the combined HIV, HCV, and opioid use disorder epidemics. The key products and services to be delivered under this award are: 1) Development of an interactive, web-based dashboard that can assist policymakers in planning an effective multi-pronged response to...
- This $575,433 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will support a research study titled "Hybrid Trial of Peer-Supported Affect Regulation and Contingency Management to Improve HIV Prevention Outcomes in the Southern United States". The grant aims to develop, pilot, and evaluate a scalable intervention called "SHE CARES" that combines contingency management and positive affect strategies to...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, is funded under the Drug Use and Addiction Research Programs (CFDA 93.279). The $660,104 award, with a performance period from August 15, 2025 to July 31, 2027, will be used by The University of Texas Southwestern Medical Center (UT Southwestern) to assess the impact of adding personalized contingency management via a mobile app (DynamiCare) to a patient navigator...
- This Cooperative Agreement award of $3,119,619 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) supports research to evaluate the effects of combining contingency management (CM) with deep transcranial magnetic stimulation (deep TMS) for the treatment of cocaine use disorder (CUD). The study aims to target brain circuitry alterations associated with CM response to improve treatment outcomes for individuals with CUD, a population that has seen...
- This $194,098 Project Grant award under the National Institute on Drug Abuse's (NIDA) Drug Use and Addiction Research Programs (CFDA 93.279) is designed to provide the principal investigator, Dr. Erath, with mentored training in implementation science to become an independent investigator focused on advancing the implementation of evidence-based treatments for stimulant use disorder and other substance use disorders in harm reduction and community treatment settings. The key objectives of the...